Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.4.10 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.47NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.41 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.71NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AS.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.142NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.166NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.4.11 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.34.2 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.50NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.60NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.52NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
W.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.250NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.63NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.130NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.44NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.469NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.311NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.93NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.104NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.225NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AV.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.309NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.105NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.307NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.171NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.57NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.67NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.279NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.67NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AD.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.201NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
W.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used